BamSEC and AlphaSense Join Forces
Learn More

Relmada Therapeutics Inc. – Indentures

NASDAQ: RLMD    
Share price (7/6/26): $6.33    
Market cap (7/6/26): $664 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 8-K 11 pages Relmada Therapeutics, Inc. Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 11 pages Relmada Therapeutics, Inc. Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 10 pages Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 10-Q 13 pages Common Stock Purchase Warrant Relmada Therapeutics, Inc
12/34/56
EX-4.1
from 10-Q 14 pages Common Stock Purchase Warrant Relmada Therapeutics, Inc
12/34/56
EX-4.2
from 10-Q 9 pages Warrant to Purchase Common Stock of Relmada Therapeutics, Inc. Void After September __, 2024
12/34/56
EX-4.1
from 10-Q 5 pages Convertible Promissory Note
12/34/56
EX-4.1
from S-3 2 pages Form of Common Stock Certificate
12/34/56
EX-4.1
from S-8 2 pages Specimen Common Stock Certificate
12/34/56
EX-4.2
from 8-K 17 pages Form of B Warrant Exhibit B-2
12/34/56
EX-4.1
from 8-K 18 pages Form of a Warrant Exhibit B-1
12/34/56
EX-4.11
from 8-K 2 pages Lock-Up Letter Agreement
12/34/56
EX-4.10
from 8-K 2 pages Lock-Up Letter Agreement
12/34/56
EX-4.9
from 8-K 2 pages Lock-Up Letter Agreement
12/34/56
EX-4.8
from 8-K 6 pages Option to Purchase Common Stock of Relmada Therapeutics, Inc
12/34/56
EX-4.7
from 8-K 5 pages Option to Purchase Common Stock of Relmada Therapeutics, Inc
12/34/56
EX-4.6
from 8-K 7 pages Option to Purchase Common Stock of Relmada Therapeutics, Inc
12/34/56
EX-4.5(II)
from 8-K 6 pages Option to Purchase Common Stock of Relmada Therapeutics, Inc
12/34/56
EX-4.5(I)
from 8-K 7 pages Option to Purchase Common Stock of Relmada Therapeutics, Inc
12/34/56
EX-4.4
from 8-K 17 pages Form of B Warrant
12/34/56